Autres langues BioHarvest Sciences Inc. Canadian Securities Exchange

Actions

BHSC

CA13767B1013

Temps Différé Canadian Securities Exchange Autres places de cotation 16:24:58 05/10/2021			Varia. 5j.	Varia. 1 janv.
0,35 ^CAD	+6,06 %		-2,94 %	+46,67 %

16/04	BioHarvest Sciences Inc. annonce la construction d'un nouveau campus pour son CDMO de synthèse botanique et l'augmentation de sa capacité de production	CI
26/02	BioHarvest Sciences Inc. annonce le lancement d'une nouvelle unité commerciale de développement et de fabrication sous contrat (Contract Development and Manufacturing Organization)	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility	18/04
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences adds key hires as company looks to ramp up CDMO Services Business Unit	27/03
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables	21/03
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024	14/03
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit	13/03
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024	07/03
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time	29/02
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules	26/02
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit	26/02
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm	20/02
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program	15/02
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference	12/02
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update	08/01
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement	27/12
BioHarvest Sciences Inc. announced that it has received CAD 13.622872 million in funding	27/12
BioHarvest Sciences to Present at the Life Sciences Investor Forum December 14th	14/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BioHarvest Sciences Inc. Canadian Securities Exchange

Actions

BHSC

CA13767B1013

Autres langues

Filtres